Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jerry S Wolinsky

Showing results (11-20 of 139) with videos related to

Pageof 14
Sort By:
Journal of the Neurological Sciences|May 12, 2009
Glatiramer acetate treatment in PPMS: why males appear to respond favorablyJerry S Wolinsky, Tzippy Shochat, Sivan Weiss, et al.
Neuroimaging Clinics of North America|December 10, 2008
Proton magnetic resonance spectroscopy in multiple sclerosisBalasrinivasa R Sajja, Jerry S Wolinsky, Ponnada A Narayana
Neurorx : the Journal of the American Society for Experimental Neurotherapeutics|May 18, 2005
Imaging of multiple sclerosis: role in neurotherapeuticsRohit Bakshi, Alireza Minagar, Zeenat Jaisani, et al.
Annals of Neurology|February 3, 2004
Multiple sclerosis: should MR criteria for dissemination in time be less stringentChris H Polman, Jerry S Wolinsky, Stephen C Reingold
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 1, 2005
Multiple sclerosis diagnostic criteria: three years laterChris H Polman, Jerry S Wolinsky, Stephen C Reingold
Therapeutic Advances in Neurological Disorders|December 24, 2010
Evolving expectations around early management of multiple sclerosisRalf Gold, Jerry S Wolinsky, Maria Pia Amato, et al.
European Neurology|June 25, 2005
Disease management in multiple sclerosisDavid Bates, Klaus V Toyka, Jerry S Wolinsky, et al.
The Lancet. Neurology|August 28, 2003
Interferon-beta antibodies: implications for the treatment of MSJerry S Wolinsky, Klaus V Toyka, Ludwig Kappos, et al.
AJNR. American Journal of Neuroradiology|January 21, 2003
Short-term correlations between clinical and MR imaging findings in relapsing-remitting multiple sclerosisMarco Rovaris, Giancarlo Comi, David Ladkani, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 3, 2012
EDSS variability before randomization may limit treatment discovery in primary progressive MSJiameng Zhang, Emmanuelle Waubant, Gary Cutter, et al.
Pageof 14

Showing results (11-20 of 139) with videos related to

Sort By:
Pageof 14
Journal of the Neurological Sciences|May 12, 2009
Glatiramer acetate treatment in PPMS: why males appear to respond favorablyJerry S Wolinsky, Tzippy Shochat, Sivan Weiss, et al.
Neuroimaging Clinics of North America|December 10, 2008
Proton magnetic resonance spectroscopy in multiple sclerosisBalasrinivasa R Sajja, Jerry S Wolinsky, Ponnada A Narayana
Neurorx : the Journal of the American Society for Experimental Neurotherapeutics|May 18, 2005
Imaging of multiple sclerosis: role in neurotherapeuticsRohit Bakshi, Alireza Minagar, Zeenat Jaisani, et al.
Annals of Neurology|February 3, 2004
Multiple sclerosis: should MR criteria for dissemination in time be less stringentChris H Polman, Jerry S Wolinsky, Stephen C Reingold
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 1, 2005
Multiple sclerosis diagnostic criteria: three years laterChris H Polman, Jerry S Wolinsky, Stephen C Reingold
Therapeutic Advances in Neurological Disorders|December 24, 2010
Evolving expectations around early management of multiple sclerosisRalf Gold, Jerry S Wolinsky, Maria Pia Amato, et al.
European Neurology|June 25, 2005
Disease management in multiple sclerosisDavid Bates, Klaus V Toyka, Jerry S Wolinsky, et al.
The Lancet. Neurology|August 28, 2003
Interferon-beta antibodies: implications for the treatment of MSJerry S Wolinsky, Klaus V Toyka, Ludwig Kappos, et al.
AJNR. American Journal of Neuroradiology|January 21, 2003
Short-term correlations between clinical and MR imaging findings in relapsing-remitting multiple sclerosisMarco Rovaris, Giancarlo Comi, David Ladkani, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 3, 2012
EDSS variability before randomization may limit treatment discovery in primary progressive MSJiameng Zhang, Emmanuelle Waubant, Gary Cutter, et al.
Pageof 14